ADMA Biologics (ADMA) Recieves $4M in Capital Through Amended Loan and Security Agreement with Oxford Finance
Tweet Send to a Friend
ADMA Biologics, Inc. (NASDAQ: ADMA) today announced that it has accessed an additional $4.0 million from its lender, Oxford Finance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
